Guggenheim reiterates Warner Brothers Discovery stock rating at Neutral

Guggenheim reiterated a Neutral rating on Warner Bros. Discovery ahead of 2Q earnings, nudging consolidated EBITDA estimates to $1.87B (from $1.85B), in line with consensus. The firm projects Studios EBITDA to fall ~65% YoY to ~$300M due to a film slate tracking below expectations, and forecasts advertising at Networks down 21% amid an intensified NBA headwind (partly offset by ~400 bps net benefit from NCAA/NHL coverage). Separately, the proposed $110B Paramount Skydance takeover faces UK review (CMA decision by Aug. 7; potential plurality concerns) while EU regulators are reportedly poised to approve with remedies, keeping deal uncertainty as shares have already risen 129% over the past year.

Analysis

WBD is in the awkward zone where near-term fundamentals are soft, but the stock is not trading purely on fundamentals anymore. That matters because the main upside from streaming mix improvement is being offset by a studio slate that can swing EBITDA materially quarter to quarter, while the broader equity increasingly prices a control premium that won’t be realized for many quarters and still faces regulatory friction. In other words, the stock is being asked to bridge a 1-3 month earnings miss risk and a 6-18 month deal optionality story at the same time.

The second-order issue is distribution power. Any incremental engagement on third-party bundles and ad-lite tiers helps Amazon more than it helps WBD: AMZN becomes the customer interface, monetization layer, and retention gatekeeper, while WBD remains the content supplier with less pricing power. If that channel mix keeps working, it can stabilize ARPU, but it also makes WBD more dependent on platform partners and less able to capture the full economics of subscriber growth.

The main contrarian point is that the market may be over-penalizing the film miss while underestimating how much of WBD’s valuation is already being anchored by deal expectations. If regulatory noise escalates or the transaction timetable slips, the stock can de-rate quickly because the strategic floor moves lower; if, however, Q3 confirms the streaming step-up and the CMA/EU path stays manageable, downside should compress. The cleanest falsifier is any sign that streaming acceleration stalls after the related-party lapse benefit is fully visible, or that regulators force remedies severe enough to make the 2026 close look uncertain.

Key Decisions for Investors

• Avoid initiating fresh outright longs in WBD before earnings; the risk/reward is asymmetric to the downside for the next 2-4 weeks because the market can punish any studios miss more than it rewards modest EBITDA in-line prints.
• If already long WBD, hedge into the Aug. 7 UK CMA decision with a short-dated put spread; the goal is to protect against a regulatory delay rather than a total deal break, since the timeline risk is the real catalyst over the next 1-3 months.
• Consider a relative-value long AMZN / short WBD basket only as a thematic expression of distribution power, not as a high-conviction pair; AMZN benefits from engagement and checkout control, while WBD remains exposed to content volatility and bargaining leakage.
• Use any post-earnings strength in WBD to trim or sell calls rather than add; the stock likely trades like a capped-upside event name until there is clearer evidence that streaming gains can offset studio and TV ad drag on a sustained basis.
• Watch for a 10%+ downside move on any regulatory setback or guidance cut; that would be the point to reassess for a tactical long only if the merger spread widens materially and remains disconnected from the deal break probability.